News Image

C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.

Provided By GlobeNewswire

Last update: Oct 15, 2024

Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience Overseeing Drug Discovery and Expansion of Leading Discovery and Clinical Portfolios

Read more at globenewswire.com

C4 THERAPEUTICS INC

NASDAQ:CCCC (2/21/2025, 8:05:56 PM)

After market: 3.01 0 (0%)

3.01

+0.02 (+0.67%)



Find more stocks in the Stock Screener

Follow ChartMill for more